抑制SGLT2和的恒温
Biff F Palmer1, Deborah J Clegg2
1Division of Nephrology, Department of Medicine, University of Texas Southwestern Medical Center, Dallas, Texas.
-葡萄糖转运体2 (SGLT2) 抑制剂很少引起 (K+) 水平的干扰. 对脏K +分泌的相互冲突的生理影响似乎相互平衡,防止常见的乱血症.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
背景情况:
- -葡萄糖载体2 (SGLT2) 抑制剂用于治疗2型糖尿病和心力衰竭.
- 靠近管管中的SGLT2抑制影响脏的 (K+) 处理.
- 生理学变化表明,K+排泄的增加和减少都有可能.
研究的目的:
- 审查SGLT2抑制剂对脏K+分泌的生理影响.
- 解释SGLT2抑制剂不常见发生的血K+度障碍 (失血症).
- 为了阐明在特定患者群体中对高血症的保护作用.
主要方法:
- 通过SGLT2抑制剂诱导的生理变化的审查.
- 对血K+水平的临床观察结果的分析.
- 讨论影响脏K+处理的因素.
主要成果:
- SGLT2 抑制剂对脏K+ 排泄产生相反的生理效应.
- 血K+度障碍在使用SGLT2抑制剂时很罕见.
- 这些药物可以在患有功能减弱的患者或服用氨酸-氨酸-阿尔多斯特轴阻塞剂的患者中预防高胆血症.
结论:
- 在K+处理上SGLT2抑制剂的对立作用可能会相互抵消,这解释了dyskalemias的罕见性.
- SGLT2 抑制剂似乎比引起低血更能减轻高血的风险.
- 需要进一步对人类进行研究,以充分阐明SGLT2抑制下K+处理的决定因素.
更多相关视频
08:46Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium
Published on: September 1, 2015
10:08Study of the Functions and Activities of Neuronal K-Cl Co-Transporter KCC2 Using Western Blotting
Published on: December 9, 2022
相关概念视频
Antihypertensive Drugs: Potassium-Sparing Diuretics
Regulation of Sodium and Potassium
Sodium Regulation
Sodium ions make up approximately 90% of extracellular cations, with a normal blood plasma concentration of 136–148 mEq/L. A decrease in blood volume and pressure triggers the release of renin from granular cells in the juxtaglomerular complex (JGC), primarily...
Renal Drug Excretion: Tubular Reabsorption
Physiology of the Genitourinary System II: Tubular Reabsorption and Secretion
Glomerular Filtration Rate and its Regulation
GFR regulation involves two primary intrinsic controls: the myogenic and tubuloglomerular feedback mechanisms.
The myogenic...
Secondary Active Transport
